FOOD
AND DRUG ADMINISTRATION
VACCINES
AND RELATED BIOLOGICAL PRODUCTS ADVISORY COMMITTEE
MEETING
ON INFLUENZA VIRUS VACCINE FORMULATION FOR 2003-2004
MEETING BY
TELECONFERENCE
Tuesday,
March 18, 2003
Food and
Drug Administration
5515
Security Lane
Conference
Room A on the 11th Floor
Suite
1113, Rockville, MD
10:30 AM
EST
10:30 AM
Call to Order
Dr. David Stephens, Committee Chair
10:35
Announcements
Dr. Jody Sachs, FDA
10:40
Open Session
Strain Selection for the Influenza Virus Vaccine for
2003-2004
Introduction and Review
Dr. Levandowski, FDA
Additional Information, H3N2
Dr. Nancy Cox, CDC
11:10
Committee
Discussion
Dr.
Levandowski, FDA
11:30
Open
Public Hearing
12:30
Recommendations
for Influenza Virus Vaccine for 2003-2004
12:45
Adjournment